Pelvic Venous Disorders in Women due to Pelvic Varices: Treatment by Embolization: Experience in 520 Patients.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 17 07 2019
revised: 03 02 2020
accepted: 22 06 2020
pubmed: 29 8 2020
medline: 25 11 2020
entrez: 29 8 2020
Statut: ppublish

Résumé

The purpose of this study was to determine the efficacy and safety of embolization treatment in pelvic venous disorders in women refluxing in the ovarian and or internal iliac veins in women with chronic pelvic pain. A retrospective study conducted from January 2000 to June 2017 in 617 patients diagnosed with pelvic venous disorders (PeVDs) with a mean age of 43.2 ± 7.2 years were treated using an embolization procedure. A total of 520 were included, and 97 patients were excluded. The main inclusion criteria were PeVD symptoms for more than 6 months and transvaginal Doppler ultrasonography (TV-DUS) diagnosis of varicose veins in the pelvis with a diameter greater than 6 mm. The main objective was to embolize the 4 main pelvic venous plexi (ovarian and internal iliac veins) whenever possible. Follow-up was performed using clinical symptoms (visual analog scale) and TV-DUS at 1, 3, 6, and 12 months and then every year up to 5 years. The technical success (embolization of the 4 main pelvic veins) was achieved in 84.4% of the patients. The average follow-up was 58.7 ± 5.7 months. The visual analog scale was improved from 7.63 ± 0.9 points pretreatment to 0.91 ± 1.5 at 5 years. A total of 26 patients (5%) presented with symptom recurrence and pelvic varicose veins. There were 57 minor complications (10.9%) and 11 major complications (2.1%), with 7 cases (1.34%) of device migration to the lung. The embolization of pelvic varicose veins is a safe and effective procedure. The selection of the embolic agents and the number of veins needed to be treated.

Identifiants

pubmed: 32855049
pii: S1051-0443(20)30534-0
doi: 10.1016/j.jvir.2020.06.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1560-1569

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 SIR. Published by Elsevier Inc. All rights reserved.

Auteurs

Miguel A De Gregorio (MA)

Department of Interventional Radiology, Hospital Clínico Universitario Lozano Blesa, University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain; Minimally Invasive Techniques Research Group (GITMI), University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain. Electronic address: mgregori@unizar.es.

José A Guirola (JA)

Department of Interventional Radiology, Hospital Clínico Universitario Lozano Blesa, University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain; Minimally Invasive Techniques Research Group (GITMI), University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain.

Enrique Alvarez-Arranz (E)

Department of Interventional Radiology, Hospital Clínico Universitario Lozano Blesa, University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain; Minimally Invasive Techniques Research Group (GITMI), University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain.

María Sánchez-Ballestin (M)

Department of Interventional Radiology, Hospital Clínico Universitario Lozano Blesa, University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain; Minimally Invasive Techniques Research Group (GITMI), University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain.

José Urbano (J)

Minimally Invasive Techniques Research Group (GITMI), University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain; Interventional Radiology, Ramón y Cajal Hospital, Madrid, Spain.

Sergio Sierre (S)

Minimally Invasive Techniques Research Group (GITMI), University of Zaragoza, Domingo Miral s/n, Zaragoza 50009, Spain; Department of Interventional Radiology, Hospital Universitario Austral, Derqui, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH